Sign in to continue:

Thursday, July 30th, 2026

LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101

  • Company Status and Regulatory Filing:

    • LifeMD is not a well-known seasoned issuer and is not an emerging growth company.
    • It has complied with all SEC filing requirements and submitted all Interactive Data Files as required.
  • Shareholder and Market Information:

    • Common Stock: Par value \$0.01 per share, trading under symbol LFMD on Nasdaq.
    • Preferred Stock: Series A Cumulative Perpetual Preferred Stock (8.875%, par value \$0.0001 per share), trading under symbol LFMDP on Nasdaq.
    • Public Float: \$512,472,017 as of June 30, 2025.
    • Outstanding Shares: 47,973,844 shares as of March 9, 2026.
  • Incorporated Documents:

    • Portions of the 2026 definitive proxy statement, to be filed within 120 days of year-end, are incorporated by reference. This may contain details about board changes, executive compensation, and governance that could affect share value.
  • View LifeMD, Inc. Historical chart here



    Dine Brands Global, Inc. (DIN) Q1 2026 Earnings: Financial Performance, Key Metrics, and SEC 10-Q Highlights

    Dine Brands Global, Inc. Q1 2026 Results: Key Highlights for...

    Mesa Laboratories, Inc. Appoints New Chief Accounting Officer and Signs Executive Employment Agreement

    Mesa Laboratories, Inc. Files Form 8-K: Key Executive Appoin...